去年，KORU Medical Systems Inc表现最佳的业务板块Domestic Core实现营收27.99M美元。Domestic的营收贡献最高，去年达到30.24M美元。最近一个季度，截至2026-06-30，KORU Medical Systems Inc表现最佳的业务板块Domestic Core实现营收7.98M美元。Domestic的营收贡献最高，达到8.40M美元。

业务

营业收入

占比

年报

年报

单季报

Domestic Core

International Core

Pharma services and clinical traials

Novel Therapies

FY2025

FY2024

FY2023

FY2022

Domestic Core

27.99M(64.53%)

25.21M(69.97%)

22.45M(74.84%)

21.21M(69.70%)

International Core

10.88M(25.08%)

6.04M(16.77%)

4.60M(15.32%)

4.16M(13.69%)

Pharma services and clinical traials

2.25M(5.20%)

2.39M(6.63%)

1.48M(4.92%)

2.53M(8.30%)

Novel Therapies

2.25M(5.20%)

2.39M(6.63%)

1.48M(4.92%)

2.53M(8.30%)

地区

营业收入

占比

年报

年报

单季报

Domestic

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

Domestic

30.24M(73.52%)

27.51M(81.75%)

23.68M(83.02%)

23.59M(84.55%)

19.49M(82.97%)

20.68M(85.53%)

International

10.89M(26.48%)

6.14M(18.25%)

4.84M(16.98%)

4.31M(15.45%)

4.00M(17.03%)

3.50M(14.47%)